H. Lundbeck A/S
- Country
- 🇩🇰Denmark
- Ownership
- Public, Subsidiary
- Established
- 2000-01-01
- Employees
- 5.6K
- Market Cap
- -
- Website
- http://www.lundbeck.com
Real-life Effectiveness of Vortioxetine in Depression
- First Posted Date
- 2018-06-13
- Last Posted Date
- 2021-05-27
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 992
- Registration Number
- NCT03555136
- Locations
- 🇺🇸
Pharmacology Research Institute (US0045), Newport Beach, California, United States
🇺🇸Maxblue Institute (US0038), Hialeah, Florida, United States
🇺🇸Northwest Behavioral Research Center (US0007), Marietta, Georgia, United States
Single Ascending Dose Study of Lu AF76432 in Healthy Young Men
- First Posted Date
- 2018-05-21
- Last Posted Date
- 2019-04-12
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 42
- Registration Number
- NCT03531229
- Locations
- 🇬🇧
Parexel Early Phase Clinical Unit, Harrow, United Kingdom
Bioequivalence Study to Compare Two Formulations of Deanxit®
- Conditions
- First Posted Date
- 2018-03-21
- Last Posted Date
- 2024-02-29
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 60
- Registration Number
- NCT03472651
- Locations
- 🇨🇳
CN1036 Shijitan Hospital, Beijing, China
Bioequivalence Study of Lu AF35700
- Conditions
- Interventions
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2018-11-29
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 87
- Registration Number
- NCT03394482
- Locations
- 🇬🇧
Covance, Leeds, United Kingdom
Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease
- First Posted Date
- 2017-10-12
- Last Posted Date
- 2018-04-04
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 3
- Registration Number
- NCT03307993
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment
- First Posted Date
- 2017-08-07
- Last Posted Date
- 2019-09-30
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 23
- Registration Number
- NCT03241147
- Locations
- 🇩🇪
APEX, Munich, Germany
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
- Conditions
- Interventions
- First Posted Date
- 2017-07-27
- Last Posted Date
- 2020-01-21
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 119
- Registration Number
- NCT03230864
- Locations
- 🇧🇬
DCC St. Vrach and St.St. Kuzma and Damian, Sofia, Bulgaria
🇧🇬MHC - Sofia, Sofia, Bulgaria
🇧🇬UMHAT, Pleven, Bulgaria
Effects of Repeated Doses of Lu AF35700 on Drug Metabolizing Enzymes
- Conditions
- Interventions
- First Posted Date
- 2017-06-22
- Last Posted Date
- 2018-01-08
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 24
- Registration Number
- NCT03195946
- Locations
- 🇬🇧
Covance Clinical Research Unit Ltd, Leeds, United Kingdom
Study Investigating the Pharmacokinetic Properties of the Drug Lu AF35700 in Subjects With Liver Impairment and in Healthy Subjects
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2018-05-04
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 24
- Registration Number
- NCT03189615
- Locations
- 🇩🇪
APEX, Munich, Germany
Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of Age
- First Posted Date
- 2017-04-11
- Last Posted Date
- 2021-06-24
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 94
- Registration Number
- NCT03108625
- Locations
- 🇵🇱
Centrum Badan Klinicznych PI-House Sp. z o.o., Gdańsk, Poland
🇵🇱Samodzielny Publiczny Zaklad Opieki Zdrowotnej (SPZOZ) - Centrum Neuropsychiatrii "NEUROMED", Wrocław, Poland
🇷🇸Clinic of Neurology and Psychiatry for Children and Adolescents, Belgrade, Serbia